Viral hepatitis: C Flashcards
Define viral hepatitis C
Hepatitis caused by infection w/ hepatitis C virus (HCV), often following chronic course (in 80% cases)
Aetiology of viral hepatitis C
type, 2, transmission
HCV is a small, enveloped, single stranded RNA virus
RNA viruses have poor fidelity of replication & mutation rates are high
So there’s lots of HCV genotypes (that can coexist in patient)
Transmission is parenteral
sexual or vertical
Pathogenesis of viral hepatitis C
2 + 4 biopsy
Virus not thought to be directly hepatotoxic
Humoral & cell mediated responses to infection that lead to hepatic inflammation & necrosis
Liver biopsy shows:
chronic hepatitis
lymphoid follicles in portal tracts
fatty change
cirrhosis may be present
Risk factors for viral hepatitis C
6
Receipts of blood & blood products IV drug users Non sterile acupuncture Tattooing Haemodialysis Health care workers
Epidemiology of viral hepatitis C
general, location
COMMON
Different genotypes of HCV have different geographical prevalence
Presenting symptoms of viral hepatitis C
3
90% acute infections are ASYMPTOMATIC
10% become jaundiced w/ mild flu like symptoms
May be diagnosed after incidental abnormal LFT
Signs of viral hepatitis C on physical examination
general, 1 + 2 rare
May be NO SIGNS
May be signs of chronic liver disease (if long standing infection)
Extra hepatic manifestations (rare):
skin rash
renal dysfunction (due to glomerulonephritis)
Investigations for viral hepatitis C
2
Bloods
Liver biopsy
Investigations for viral hepatitis C - bloods
3
HCV serology
anti HCV antibodies: IgM (acute) or IgG (past exposer or chronic)
Reverse transcriptase PCR
allows detection & genotyping
LFT
acute infection: high ALT, AST, bilirubin
chronic infection: 2-8x elevation of AST & ALP (often fluctuates oner time)
Investigations for viral hepatitis C - liver biopsy
3
Assess degree of inflammation & liver damage
Transaminase (AST & ALT) levels have little correlation to histological changes
Useful for diagnosing cirrhosis
Management of viral hepatitis C
2
Prevention
Medical
Management of viral hepatitis C - prevention
4
Screen blood, blood products & organ donors
Needle exchange schemes for IV drug users
Instrument sterilisation
No vaccine available
Management of viral hepatitis C - medical
acute + 2 chronic +1
Acute Mainly supportive (antipyretic, antiemetics, cholestyramine)
Chronic
Pegylated interferon-α
Ribavirin (guanosine nucleotide analogue)
Duration of HCV genotype 1/4 are 24-48 weeks & 2/3 are 12-24 weeks
Regular US of liver may be needed if patient has cirrhosis
Complications of viral hepatitis C
4
Fulminant hepatic failure
Chronic carriage of HCV
Hepatocellular carcinoma
Less common: porphyria cutanea tarda, cryoglobulinaemia, glomerulonephritis
Prognosis of viral hepatitis C
2
80% of exposed will progress to chronic carriage
Of these 20-30% develop cirrhosis over 10-20 yrs